A novel method for diagnosing and managing prostate cancer has been developed.
Browsing: MRI scan
Three hospitals in the UK are trialing a ‘one-stop’ prostate cancer diagnosis service, which is expected to reduce the time taken for a diagnosis from approximately 6 weeks to just days.
Prostate cancer screening and detection remain challenging issues, with changes in recommendations for prostate-specific antigen testing causing a significant change in approach. In this editorial discover the multiple roles and applications of prostate MRI.
A tumor-targeting Magnetic Resonance Imaging (MRI) contrast, based on human proteins has been designed, that is also cleared easily by the body. The development has promise for clinical application.
This review discusses the key sequences that comprise a mpMRI exam of the prostate gland including technical factors that affect image quality, such as pre-exam patient preparation, magnet field strength, endorectal coil utilization and sequence parameters.
This review outlines the strengths and limitations of each of the different imaging modalities for prostate cancer as well as individual tracers used, including preclinical and clinical agents.
Emerging therapies are using MRI-guided focal therapy, this review discusses the various MRI techniques for men undergoing treatment for prostate cancer
Find out about how the UK’s National Physical Laboratory (NPL) is enabling greater confidence in radiotherapy, leading to accelerated implementation of the most advanced techniques and helping to ensure patients receive the same standard of treatment irrespective of where they receive their treatment.
Discover the potential role for prostate multiparametric MRI and targeted biopsy techniques incorporating MRI into active surveillance in this article from Future Oncology.
This opinion article discusses GRPR as a biomarker for molecular imaging of various types of cancers, as well as the development of a protein-based MRI contrast agent against GRPR.